Literature DB >> 3735078

Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation.

P R Byron.   

Abstract

A mathematical model was developed for predicting drug residence kinetics in various regions of the human respiratory tract (RT). The model allows for regional deposition of different dose fractions (following mouth inhalation of various particle sizes according to four popular breathing regimes). Predicted alveolar deposition was dependent on the mode of inhalation and breath-holding. Deposition in the ciliated airways, however, was largely unaffected by breath-holding and was at a maximum for aerodynamic diameters between 5-9 micron (slow inhalation) and 3-6 microns (fast inhalation). Selected mucociliary and absorption rate constants determined the durations (T) taken to deplete the initial deposition in a chosen lung region to a selected minimum dose fraction (MDF). Values of T for an MDF of 0.01 in the ciliated airways were dependent on aerosol size, mode of inhalation, and rate of dissolution. In the case of rapidly dissolving solutes, the maximum duration was short (1-2 h) and occurred at particle sizes and modes of inhalation which maximized deposition in the conducting airways. For less soluble particles, however, T in the same airways could approach 12 h due to a prolonged supply of particles from the alveolar regions. The optimal size distribution and the mode of inhalation for maximum duration differed substantially in each case. The model enables formulation of testable hypotheses relating to the extension of local drug residence in the RT following inhalation of therapeutic aerosols.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3735078     DOI: 10.1002/jps.2600750502

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  49 in total

1.  Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

2.  Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

3.  Optimized inhalation aerosols. II. Inertial testing methods for particle size analysis of pressurized inhalers.

Authors:  E M Phillips; P R Byron; K Fults; A J Hickey
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

4.  Model of disposition of drugs administered into the human nasal cavity.

Authors:  I Gonda; E Gipps
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

5.  Aerosol deposition characteristics in distal acinar airways under cyclic breathing conditions.

Authors:  Baoshun Ma; Chantal Darquenne
Journal:  J Appl Physiol (1985)       Date:  2011-02-17

6.  Convective flow dominates aerosol delivery to the lung segments.

Authors:  C Darquenne; C van Ertbruggen; G K Prisk
Journal:  J Appl Physiol (1985)       Date:  2011-04-07

Review 7.  Clinical pharmacokinetics of inhaled antimicrobials.

Authors:  Chris Stockmann; Jessica K Roberts; Venkata K Yellepeddi; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

8.  Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.

Authors:  Jahidur Rashid; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-11       Impact factor: 5.464

9.  Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.

Authors:  Jahidur Rashid; Ahmad Alobaida; Taslim A Al-Hilal; Samia Hammouda; Ivan F McMurtry; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  J Control Release       Date:  2018-04-30       Impact factor: 9.776

10.  Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery.

Authors:  Pardis Kalantarian; Abdolhosein Rouholamini Najafabadi; Ismaeil Haririan; Alireza Vatanara; Yadollah Yamini; Majid Darabi; Kambiz Gilani
Journal:  Int J Nanomedicine       Date:  2010-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.